Investors / Singapore / Panacea Capital
Panacea Capital
Venture capital · Singapore, Singapore · Asia Pacific
Panacea Capital is a life sciences venture fund spun out from Kleiner Perkins in 2017. It has raised three USD funds and holds investments in more than 30 private companies and several public companies, with offices in Singapore, Taiwan, Shanghai, Boston, New York and Silicon Valley.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechtherapeuticsdiagnosticsmedtechpublic markets
Your fit with Panacea Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsPanacea Capital lists 21 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 30% of its companies are based in United States. It invests most often alongside WI Harper Group, 3B Future Health Fund and BroadOak Capital Partners.
No funding round on record names Panacea Capital yet, so the figures come from its portfolio page.
Round figures show recent activity, not Panacea Capital's whole history. Rounds on record name 0 companies; its own site lists 21. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 53th | 21 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 84th | 6 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers21100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Panacea Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
21 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| The company addresses the unmet health care needs of patients suffering from cardiovascular diseases. | Healthcare & Biotech | Portfolio page | ||
| Base Therapeutics develops gene editing technologies and immune cell therapies | Healthcare & Biotech | Portfolio page | ||
| Chime Biologics is a leading global CDMO, focused on ensuring our customers' success in delivering innovative biologics as well as biosimilars to patients across the world. | Healthcare & Biotech | Portfolio page | ||
| Coastar Therapeutics develops genetic medicine delivery technology | Healthcare & Biotech | Portfolio page | ||
| Domain Therapeutics develops breakthrough GPCR-targeting therapies for patients, especially in immuno-oncology and inflammation. | Healthcare & Biotech | Funding round | ||
| The company incubates, launches, and builds early-stage companies emerging from leading academic labs and research institutions in the field of regenerative medicine. | Healthcare & Biotech | Portfolio page | ||
| Portfolio page | ||||
| Portfolio page | ||||
| Harvest Integrated Research Organization (HiRO) delivers end-to-end clinical trial services | Healthcare & Biotech | Portfolio page | ||
| Human Longevity Inc. provides early detection and prevention services for various diseases through genome sequencing, whole body MRI, and other diagnostics. | Healthcare & Biotech | Portfolio page | ||
| Kindstar Global provides medical testing and inspection services, including hematology, genetic, and oncology testing, as well as online healthcare services. | Healthcare & Biotech | Portfolio page | ||
| MaavRx is developing a one-time treatment to restore lifelong constant production of L-DOPA in patients with advanced Parkinson's disease. | Healthcare & Biotech | Portfolio page | ||
| Miragene is pioneering a new generation of therapies to address immunological and inflammatory diseases. | Healthcare & Biotech | Portfolio page | ||
| Myrtelle is transforming the treatment of myelin-based diseases, including white matter disorders | Healthcare & Biotech | Portfolio page | ||
| Neurochase is a biotechnology company developing innovative devices and consulting services for targeted CNS drug delivery. | Healthcare & Biotech | Portfolio page | ||
| OutSee develops and uses a predictive AI engine for genomics led discovery | Healthcare & Biotech | Funding round | ||
| Regatta Bio is advancing the next generation of regulatory T cell therapies to address challenges in immune health | Healthcare & Biotech | Portfolio page | ||
| Seismic Pharmaceuticals develops medications for heart failure and cardiogenic shock | Healthcare & Biotech | Portfolio page | ||
| Tactiva Therapeutics develops adoptive cell therapy strategies for cancer treatment | Healthcare & Biotech | Portfolio page | ||
| TriArm Therapeutics focuses on innovative cell therapy and new drug development | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- panaceacapital.com
- Last read
- 5 Nov 2026
- Watching since
- 5 Nov 2026
- Companies checked
- 21
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Panacea Capital's profile as data
Pull Panacea Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/panaceacapital.com
# also
GET /v1/firms/panaceacapital.com/portfolio
GET /v1/firms/panaceacapital.com/coinvestors
GET /v1/firms/panaceacapital.com/news